Principia Biopharma Inc Revenue per Employee (PRNB), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Principia Biopharma Inc   (NASDAQ: PRNB)
 

Principia Biopharma Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 66.67% in the second quarter 2020, year on year to cumulative value of $50 million, Principia Biopharma Inc 's revenue per employee grew on a trailing twelve months basis to $ 500,000, this is below the company average.
Within the Healthcare sector Principia Biopharma Inc achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .Principia Biopharma Inc has 100 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PRNB Revenue per Employee (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter
Y / Y Revenue Change 66.67 % - - - 131 %
Sales per Employee (TTM) $ 500,000 300,000 351,600 612,970 798,610
PRNB's Total Ranking # # # # # 904
Seq. Revenue Change - - - - 481.4 %

PRNB Company Profile >> Back to PRNB Efficiency Comparisons >> Compare PRNB Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 798,610 $ 576,025 $ 185,640
(Jun 30 2019)   (Sep 30 2018)



Financial Statements
Principia Biopharma Inc 's Revenue MRQ $ 50 Millions Visit PRNB's Income Statement
Principia Biopharma Inc 's Revenues TTM $ 50 Millions Visit PRNB's aggregate revenue growth
What are PRNB's Sales? Visit PRNB's Sales by Segment




Other Ratios
Principia Biopharma Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
PRNB's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for PRNB's Competitors
Revenue per Employee for PRNB's Suppliers
Revenue per Employee for PRNB's Customers

You may also want to know
PRNB's Sales Growth Rates PRNB's Pe Price to earnings ratio PRNB's Receivables Turnover Ratio PRNB's Stock Quote
PRNB's Net Income Growth Rates PRNB's Ps Price to Sales ratio PRNB's Sales per Employee PRNB's Asset Turnover Ratio
PRNB's Net Margin PRNB's Pb Price to Book ratio PRNB's Financial Strength Ratios PRNB's Dividend Payout Ratio
Date modified: 2026-09-18T13:11:04+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2020, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2020Number of Employees Jun 30 2020
Exelixis Inc   870,450.74 $ 998.407  Million 1,147 
Theravance Biopharma inc   853,288.89 $ 76.796  Million 90 
Seagen Inc   846,315.83 $ 1,015.579  Million 1,200 
Incyte Corporation  839,493.67 $ 2,387.520  Million 2,844 
Durect Corp  820,770.49 $ 50.067  Million 61 
Cv Sciences Inc   809,022.73 $ 35.597  Million 44 
Abiomed Inc   798,067.00 $ 798.067  Million 1,000 
Sangamo Therapeutics Inc   784,774.65 $ 111.438  Million 142 
Collegium Pharmaceutical Inc   783,470.45 $ 331.408  Million 423 
Korro Bio Inc   771,275.86 $ 44.734  Million 58 
Jazz Pharmaceuticals Plc  766,991.00 $ 2,216.604  Million 2,890 
Intercept Pharmaceuticals inc   755,602.67 $ 283.351  Million 375 
Xoma Royalty Corporation  751,785.71 $ 10.525  Million 14 
Carlisle Companies Incorporated  737,203.39 $ 4,349.500  Million 5,900 
Esperion Therapeutics Inc   734,826.53 $ 216.039  Million 294 
Assembly Biosciences Inc   718,561.64 $ 52.455  Million 73 
Patterson Companies Inc   711,473.29 $ 5,407.197  Million 7,600 
Voyager Therapeutics Inc   708,191.49 $ 99.855  Million 141 
Ionis Pharmaceuticals Inc   670,810.27 $ 940.476  Million 1,402 
Reshape Lifesciences Inc  669,777.78 $ 12.056  Million 18 
Catalyst Pharmaceuticals Inc   658,028.76 $ 119.761  Million 182 
Pfizer Inc  655,960.00 $ 49,197.000  Million 75,000 
Supernus Pharmaceuticals inc   650,753.07 $ 424.291  Million 652 
Abbvie Inc   635,561.40 $ 36,227.000  Million 57,000 
Perrigo Company Plc  626,419.75 $ 5,074.000  Million 8,100 
Rigel Pharmaceuticals Inc  620,913.79 $ 108.039  Million 174 
Merck and Co Inc   608,986.67 $ 45,674.000  Million 75,000 
Dynatronics Corporation  606,920.98 $ 53.409  Million 88 
Prophase Labs Inc   600,947.37 $ 11.418  Million 19 
Morphic Holding inc   600,903.23 $ 18.628  Million 31 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.